JP2014505014A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014505014A5 JP2014505014A5 JP2013536845A JP2013536845A JP2014505014A5 JP 2014505014 A5 JP2014505014 A5 JP 2014505014A5 JP 2013536845 A JP2013536845 A JP 2013536845A JP 2013536845 A JP2013536845 A JP 2013536845A JP 2014505014 A5 JP2014505014 A5 JP 2014505014A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- amino acids
- amino acid
- acid sequence
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40740210P | 2010-10-27 | 2010-10-27 | |
| US61/407,402 | 2010-10-27 | ||
| US201161467894P | 2011-03-25 | 2011-03-25 | |
| US61/467,894 | 2011-03-25 | ||
| US201161502476P | 2011-06-29 | 2011-06-29 | |
| US61/502,476 | 2011-06-29 | ||
| PCT/US2011/058165 WO2012058480A1 (en) | 2010-10-27 | 2011-10-27 | Fviii peptides for immune tolerance induction and immunodiagnostics |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016230723A Division JP2017095463A (ja) | 2010-10-27 | 2016-11-29 | 免疫寛容誘導および免疫診断のためのｆｖｉｉｉペプチド |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014505014A JP2014505014A (ja) | 2014-02-27 |
| JP2014505014A5 true JP2014505014A5 (enExample) | 2014-12-11 |
| JP6122780B2 JP6122780B2 (ja) | 2017-04-26 |
Family
ID=45349271
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013536845A Expired - Fee Related JP6122780B2 (ja) | 2010-10-27 | 2011-10-27 | 免疫寛容誘導および免疫診断のためのｆｖｉｉｉペプチド |
| JP2016230723A Pending JP2017095463A (ja) | 2010-10-27 | 2016-11-29 | 免疫寛容誘導および免疫診断のためのｆｖｉｉｉペプチド |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016230723A Pending JP2017095463A (ja) | 2010-10-27 | 2016-11-29 | 免疫寛容誘導および免疫診断のためのｆｖｉｉｉペプチド |
Country Status (20)
| Country | Link |
|---|---|
| US (3) | US8969524B2 (enExample) |
| EP (2) | EP3260132B1 (enExample) |
| JP (2) | JP6122780B2 (enExample) |
| KR (2) | KR102040867B1 (enExample) |
| CN (2) | CN104926947A (enExample) |
| AR (1) | AR083586A1 (enExample) |
| AU (2) | AU2011319747C1 (enExample) |
| BR (1) | BR112013010362A2 (enExample) |
| CA (1) | CA2815239C (enExample) |
| DK (1) | DK2632479T3 (enExample) |
| EA (1) | EA034494B1 (enExample) |
| ES (2) | ES2639039T3 (enExample) |
| HK (1) | HK1215442A1 (enExample) |
| MX (1) | MX347805B (enExample) |
| NZ (2) | NZ609474A (enExample) |
| PL (2) | PL3260132T3 (enExample) |
| PT (1) | PT2632479T (enExample) |
| SG (2) | SG10201600656WA (enExample) |
| TW (3) | TW201708251A (enExample) |
| WO (1) | WO2012058480A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100256062A1 (en) | 2004-12-06 | 2010-10-07 | Howard Tommy E | Allelic Variants of Human Factor VIII |
| AU2013343024B2 (en) * | 2012-11-12 | 2017-06-01 | Worg Pharmaceuticals (Zhejiang) Co., Ltd. | Peptides |
| WO2014089541A2 (en) | 2012-12-07 | 2014-06-12 | Haplomics, Inc. | Factor viii mutation repair and tolerance induction |
| US20160038575A1 (en) * | 2013-03-15 | 2016-02-11 | Haplomics, Inc. | Compositions and methods for immune tolerance induction to factor viii replacement therapies in subjects with hemophilia a |
| WO2017180807A1 (en) | 2016-04-15 | 2017-10-19 | Baxalta Incorporated | Method and apparatus for providing a pharmacokinetic drug dosing regiment |
| CA2951150C (en) * | 2014-06-12 | 2024-05-28 | University Of Hawaii | Uses of humanized cobra venom factor for reducing or preventing immunogenicity |
| JP2018504145A (ja) * | 2015-01-26 | 2018-02-15 | セレクティスＣｅｌｌｅｃｔｉｓ | 再発性／難治性急性骨髄性リンパ腫または芽球性形質細胞様樹状細胞新生物を処置するための、ｃｄ１２３に結合するキメラ抗原受容体を賦与された、操作されたｔ細胞受容体ノックアウト免疫細胞 |
| US10896749B2 (en) | 2017-01-27 | 2021-01-19 | Shire Human Genetic Therapies, Inc. | Drug monitoring tool |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20040103970A (ko) * | 2002-04-18 | 2004-12-09 | 메르크 파텐트 게엠베하 | 변형된 펙터 ⅷ |
| US7485314B2 (en) * | 2002-05-06 | 2009-02-03 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Induction of antigen specific immunologic tolerance |
| EP1766412B1 (en) * | 2004-05-21 | 2009-04-01 | The Institute for Systems Biology | Compositions and methods for quantification of serum glycoproteins |
| US20060094104A1 (en) | 2004-10-29 | 2006-05-04 | Leopold Grillberger | Animal protein-free media for cultivation of cells |
| CA2633306A1 (en) | 2006-01-04 | 2007-07-12 | Baxter International Inc. | Oligopeptide-free cell culture media |
| GB0723712D0 (en) * | 2007-12-04 | 2008-01-16 | Apitope Technology Bristol Ltd | Peptides |
| US7673687B2 (en) | 2007-12-05 | 2010-03-09 | Halliburton Energy Services, Inc. | Cement compositions comprising crystalline organic materials and methods of using same |
| DE202007017320U1 (de) | 2007-12-07 | 2008-02-28 | Dittmann, Ludwig | Vorrichtung zur Raumbeduftung |
| GB0801513D0 (en) * | 2008-01-28 | 2008-03-05 | Circassia Ltd | Peptides from factor VIII |
| WO2009099991A2 (en) | 2008-01-31 | 2009-08-13 | The Brigham And Women's Hospital, Inc. | Treatment of cancer |
| US20100168018A1 (en) | 2008-11-07 | 2010-07-01 | Baxter International Inc. | Factor viii formulations |
-
2011
- 2011-10-27 SG SG10201600656WA patent/SG10201600656WA/en unknown
- 2011-10-27 MX MX2013004753A patent/MX347805B/es active IP Right Grant
- 2011-10-27 ES ES11796846.1T patent/ES2639039T3/es active Active
- 2011-10-27 SG SG2013028733A patent/SG189914A1/en unknown
- 2011-10-27 KR KR1020137013231A patent/KR102040867B1/ko active Active
- 2011-10-27 US US13/283,452 patent/US8969524B2/en active Active
- 2011-10-27 EA EA201390617A patent/EA034494B1/ru not_active IP Right Cessation
- 2011-10-27 CN CN201510431485.4A patent/CN104926947A/zh active Pending
- 2011-10-27 ES ES17167928T patent/ES2912455T3/es active Active
- 2011-10-27 TW TW105138248A patent/TW201708251A/zh unknown
- 2011-10-27 CN CN201180063117.9A patent/CN103298482B/zh active Active
- 2011-10-27 EP EP17167928.5A patent/EP3260132B1/en active Active
- 2011-10-27 TW TW106113613A patent/TW201730205A/zh unknown
- 2011-10-27 KR KR1020197032106A patent/KR102222864B1/ko not_active Expired - Fee Related
- 2011-10-27 NZ NZ609474A patent/NZ609474A/en unknown
- 2011-10-27 PL PL17167928.5T patent/PL3260132T3/pl unknown
- 2011-10-27 PT PT117968461T patent/PT2632479T/pt unknown
- 2011-10-27 TW TW100139078A patent/TWI580430B/zh active
- 2011-10-27 CA CA2815239A patent/CA2815239C/en active Active
- 2011-10-27 AU AU2011319747A patent/AU2011319747C1/en active Active
- 2011-10-27 PL PL11796846T patent/PL2632479T3/pl unknown
- 2011-10-27 DK DK11796846.1T patent/DK2632479T3/en active
- 2011-10-27 NZ NZ703514A patent/NZ703514A/en unknown
- 2011-10-27 WO PCT/US2011/058165 patent/WO2012058480A1/en not_active Ceased
- 2011-10-27 JP JP2013536845A patent/JP6122780B2/ja not_active Expired - Fee Related
- 2011-10-27 BR BR112013010362A patent/BR112013010362A2/pt not_active Application Discontinuation
- 2011-10-27 EP EP11796846.1A patent/EP2632479B1/en active Active
- 2011-10-28 AR ARP110103988A patent/AR083586A1/es not_active Application Discontinuation
-
2015
- 2015-01-23 US US14/604,622 patent/US9512198B2/en active Active
-
2016
- 2016-03-22 HK HK16103339.6A patent/HK1215442A1/zh unknown
- 2016-04-06 AU AU2016202155A patent/AU2016202155B2/en active Active
- 2016-11-02 US US15/341,936 patent/US20170267743A1/en not_active Abandoned
- 2016-11-29 JP JP2016230723A patent/JP2017095463A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014505014A5 (enExample) | ||
| TWI880898B (zh) | 單鏈嵌合多肽及其用途 | |
| JP2013529070A5 (enExample) | ||
| DK1773872T3 (en) | VARIABLE Lymphocyte Receptors, Associated Polypeptides and Nucleic Acids, and Uses thereof | |
| JP2017524348A5 (enExample) | ||
| JP2017160222A5 (enExample) | ||
| JP2012501959A5 (enExample) | ||
| HRP20192314T1 (hr) | Pripravci faktora viii i postupci pripreme i njihove uporabe | |
| JP2017529067A5 (enExample) | ||
| JP2017018125A5 (enExample) | ||
| JP2016052315A5 (enExample) | ||
| JP2016508143A5 (enExample) | ||
| JP2015134758A5 (enExample) | ||
| JP2006515749A5 (enExample) | ||
| JP2013525305A5 (enExample) | ||
| JP2013513377A5 (enExample) | ||
| JP2013521789A5 (enExample) | ||
| JP2013517783A5 (enExample) | ||
| JP2013504589A5 (enExample) | ||
| JP2010533200A5 (enExample) | ||
| JP2014521313A5 (enExample) | ||
| JP2015514132A5 (enExample) | ||
| JP2019520038A5 (enExample) | ||
| JP2015524788A5 (enExample) | ||
| CN106046163A (zh) | 一种全人源抗CD45的全分子IgG抗体及其应用 |